Research suggests that papaya shows some potential relevance to digestive health through two distinct mechanisms: the fermentability of its dietary fiber by gut bacteria, and the proteolytic activity of its enzyme papain. The available evidence comes from two laboratory-based studies rather than clinical trials in humans, which limits how directly these findings can be applied to real-world digestive outcomes. One in vitro fermentation study found that papaya fiber, like that of other tropical fruits, produces short-chain fatty acids when broken down by gut bacteria, though the researchers themselves cautioned that further work is needed to confirm whether this translates to meaningful digestive benefits. A separate analytical study found that papaya-derived enzyme products retained greater proteolytic activity compared to pineapple-based supplements, though this work focused primarily on quality control methodology rather than health outcomes. Taken together, the current evidence is preliminary and largely preclinical, and broader human studies would be needed before stronger conclusions can be drawn.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| In vitro bacterial fermentation of tropical fruit fibres. | Other | 2013 | Supports | 100 |
| New Pipeline for Analysing Fruit Proteolytic Products Used as Digestive Healt... | Other | 2024 | Supports | 95 |